Dianthus Therapeutics Statistics

Total Valuation

DNTH has a market cap or net worth of $820.50 million. The enterprise value is $430.83 million.

Market Cap	820.50M
Enterprise Value	430.83M

Important Dates

The next estimated earnings date is Thursday, November 7, 2024, after market close.

Earnings Date	Nov 7, 2024
Ex-Dividend Date	n/a

Share Statistics

DNTH has 29.37 million shares outstanding. The number of shares has increased by 413.54% in one year.

Shares Outstanding	29.37M
Shares Change (YoY)	+413.54%
Shares Change (QoQ)	+33.36%
Owned by Insiders (%)	0.22%
Owned by Institutions (%)	55.68%
Float	13.41M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	134.85
Forward PS	484.71
PB Ratio	2.21
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	104.62
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 36.46, with a Debt / Equity ratio of 0.00.

Current Ratio	36.46
Quick Ratio	36.13
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -27.33% and return on invested capital (ROIC) is -20.67%.

Return on Equity (ROE)	-27.33%
Return on Assets (ROA)	-19.84%
Return on Capital (ROIC)	-20.67%
Revenue Per Employee	$77,698
Profits Per Employee	-$1.07M
Employee Count	53
Asset Turnover	0.02
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +130.34% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+130.34%
50-Day Moving Average	27.82
200-Day Moving Average	25.22
Relative Strength Index (RSI)	51.22
Average Volume (20 Days)	247,483

Short Selling Information

The latest short interest is 4.97 million, so 16.94% of the outstanding shares have been sold short.

Short Interest	4.97M
Short Previous Month	4.33M
Short % of Shares Out	16.94%
Short % of Float	37.10%
Short Ratio (days to cover)	25.83

Income Statement

In the last 12 months, DNTH had revenue of $4.12 million and -$56.68 million in losses. Loss per share was -$2.75.

Revenue	4.12M
Gross Profit	4.12M
Operating Income	-68.76M
Pretax Income	-56.68M
Net Income	-56.68M
EBITDA	-68.68M
EBIT	-68.76M
Loss Per Share	-$2.75

Full Income Statement

Balance Sheet

The company has $360.71 million in cash and $407,000 in debt, giving a net cash position of $360.30 million or $12.27 per share.

Cash & Cash Equivalents	360.71M
Total Debt	407,000
Net Cash	360.30M
Net Cash Per Share	$12.27
Equity (Book Value)	358.22M
Book Value Per Share	12.20
Working Capital	355.66M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$51.32 million and capital expenditures -$124,000, giving a free cash flow of -$51.44 million.

Operating Cash Flow	-51.32M
Capital Expenditures	-124,000
Free Cash Flow	-51.44M
FCF Per Share	-$1.75

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-1,669.82%
Pretax Margin	-1,376.42%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-635.79%

Dividends & Yields

DNTH does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-413.54%
Shareholder Yield	-413.54%
Earnings Yield	-7.16%
FCF Yield	-6.50%

Analyst Forecast

The average price target for DNTH is $45.14, which is 61.56% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$45.14
Price Target Difference	61.56%
Analyst Consensus	Strong Buy
Analyst Count	8
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

DNTH has an Altman Z-Score of 26.08 and a Piotroski F-Score of 2.

Altman Z-Score	26.08
Piotroski F-Score	2